{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T09:37:33Z","timestamp":1723023453886},"reference-count":0,"publisher":"European Centre for Disease Control and Prevention (ECDC)","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12,1]]},"abstract":"<jats:p>Influenza activity varied across Europe during the 2002-2003 season both in terms of the intensity of clinical activity and the circulating virus types\/subtypes. Influenza B was generally predominant in the 'western' parts of Europe (Portugal, Spain, the United Kingdom and Ireland) and influenza A (H3N2) in the 'central' and 'eastern\u00b4 areas (Germany, Italy, Denmark, Switzerland, Poland, Slovenia, the Slovak Republic, the Netherlands). A number of countries experienced mixed seasons, first experiencing activity associated with influenza B and then with influenza A (Belgium, France and Spain). Generally, countries where influenza B was predominant had low (compared to historical data) levels of intensity (a mild season) and longer periods of influenza activity compared to countries where influenza A (H3N2) was predominant. A number of countries, all where influenza A (H3N2) was predominant, reported high levels of intensity compared to historical data: the Czech Republic, Denmark, Germany and Poland. In the six countries where age-specific incidence rates were available, the highest rates were observed among those aged 0-14 years. The influenza virus strains circulating in Europe had a good match with the virus strains in the influenza vaccine. A small number of isolates (A\/Fujian\/411\/2002 (H3N2)-like) were reported at the end of the season that had a reduced reactivity to anti-sera of the vaccine strain. The composition of the 2003-2004 influenza vaccine is the same as during the 2002-2003 season.<\/jats:p>","DOI":"10.2807\/esm.08.12.00437-en","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T11:57:05Z","timestamp":1507118225000},"page":"230-239","update-policy":"http:\/\/dx.doi.org\/10.2807\/1560-7917.es.crp2020","source":"Crossref","is-referenced-by-count":8,"title":["Heterogeneous influenza activity across Europe during the winter of 2002-2003"],"prefix":"10.2807","volume":"8","author":[{"given":"W J","family":"Paget","sequence":"first","affiliation":[{"name":"European Influenza Surveillance Scheme co-ordination centre, Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands"}]},{"given":"T J","family":"Meerhoff","sequence":"additional","affiliation":[{"name":"European Influenza Surveillance Scheme co-ordination centre, Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands"}]},{"given":"H","family":"Rebelo de Andrade","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade Dr. Ricardo Jorge, Lisboa, Portugal"}]},{"name":"on behalf of EISS","sequence":"additional","affiliation":[]}],"member":"7995","container-title":["Eurosurveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T12:02:01Z","timestamp":1663243321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/esm.08.12.00437-en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12,1]]}},"URL":"https:\/\/doi.org\/10.2807\/esm.08.12.00437-en","relation":{},"ISSN":["1560-7917"],"issn-type":[{"type":"print","value":"1560-7917"}],"subject":[],"published":{"date-parts":[[2003,12,1]]}}}